Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6475.5000 63.50 (0.99%)
NSE Nov 26, 2025 12:44 PM
Volume: 53,120
 

6475.50
0.99%
Karvy
Margins impacted, Premium valuations: Divis Labs Net revenues increased by 15.5% YoY to Rs 12.6 bn, which is inlinewith our estimates for the quarter.
Deven Choksey increased Accumulate price target of Divi's Laboratories Ltd. to 6795.0 on 20 Nov, 2025.
More from Divi's Laboratories Ltd.
Recommended